Navigation Links
Bio-Organic Catalyst, Inc. Forms Joint Venture With SIF ICAP Mexico S.A. de C.V. as Exclusive Distribution Hub for Central America, Mexico and Caribbean.
Date:10/27/2009

NEW YORK, Oct. 27 /PRNewswire-FirstCall/ -- International Daleco Corporation (Pink Sheets: ILDO) announces its subsidiary, Bio-Organic Catalyst, Inc., has formed a new joint venture company, ICAP Bio Organic, S. de R.L. de C.V., as the distribution hub of its patented and proprietary bio-organic catalyst compositions (BOCs) within Central America, Mexico and Caribbean markets, as well as developing carbon reduction and renewable energy credit opportunities where available.

SIF ICAP Mexico S.A. de C.V. (http://www.sif.com.mx) is a subsidiary of the Mexican Stock Exchange (BMV) and ICAP PLC. SIF ICAP Mexico S.A. de C.V. is the largest company of this kind in Mexico and offers the broadest range of services to banks, brokerage firms, pension funds, mutual funds, corporate treasury departments and government agencies to perform their daily transactions in the fixed-income, OTC derivatives and the foreign exchange markets by using the most advanced and secure information technologies."

ICAP PLC (http://www.icap.com) is the world's premier voice and electronic interdealer broker, delivering specialist intermediary brokering services to trading professionals in the wholesale financial markets. ICAP's businesses currently operate in more than 32 countries and with over 4,300 staff worldwide.

Bio-Organic Catalyst, Inc. (www.bio-organic.com) has a proprietary trademarked product line of patented bio-organic catalyst compositions (BOCs) for advanced upgrade optimization to the systems used to treat wastewater and solid wastes, with installations in industrial and municipal facilities worldwide.

International Daleco Corporation (http://www.interdaleco.com) has financed advanced technology ventures for over 25 years. For the past decade, its primary focus has been on the revolutionary advancements Bio-Organic Catalyst, Inc. brings to the transformation of water treatment and renewable energy systems.

This News Release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based largely on the Company's expectations of forecasts of future events, can be affected by inaccurate assumptions and are subject to various risks and known and unknown uncertainties, a number of which are beyond the Company's control. Therefore, actual results could differ materially from the forward-looking statements herein.

Contact: President of International Daleco Corporation and Bio-Organic Catalyst, Inc. Parker D. Dale 917-833-1584

SOURCE International Daleco Corporation


'/>"/>
SOURCE International Daleco Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. MAQUET Cardiovascular Announces Leading Robotic Heart Surgeon Performs First Beating Heart Fully Endoscopic Bypass Surgery Using Miniaturized Cardiopulmonary Bypass System
2. Boston Scientifics Urology/Gynecology Business Forms Marketing Alliance with Bladder Health Network
3. Santaris Pharma A/S Forms Strategic Alliance With Shire plc to Develop RNA-Based Medicines for the Treatment of Rare Genetic Disorders
4. Laser technology creates new forms of metal and enhances aircraft performance
5. Surgeon Performs First Single Incision Peri-Umbilical Laparoscopic Surgery in the State of Missouri
6. Penguin Computing Forms OEM Agreement with Applied Biosystems for Scyld ClusterWare
7. Aesthera Announces ANVISA Clearance to Market Photopneumatic Platforms in Brazil
8. DATATRAK International, Inc. Forms Strategic Partnership with Inclinix, Inc.
9. Newbridge Securities Corporation Forms BioVentures Division
10. Cordex Pharma Forms Heart Failure Medical Advisory Board
11. NASDAQ OMX AeA Illinois Tech Index Outperforms Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ... ... NDA Partners Chairman Carl Peck, MD , announced today that John W. ... Center for Devices and Radiological Health and recognized leader in the medical device, pharmaceutical ... his FDA experience, Dr. Sheets served in senior technical leadership roles in a series ...
(Date:8/21/2017)... USA (PRWEB) , ... August 20, 2017 , ... ... the Journal of Biomedical Optics (JBO) starting 1 January 2018. The journal is ... of Biomedical Optics publishes papers on the use of modern optical technology for ...
(Date:8/21/2017)... ... August 21, 2017 , ... The team at ... educational webinar, in which attendees will learn about the assembly and topological architecture ... with an overview of the development and validation of new high-quality recombinant monoclonal ...
(Date:8/17/2017)... Westlake Village, CA (PRWEB) , ... August 17, ... ... biopsy technology for cancer research and personalized medicine, today announced the launch of ... in Kansas City, Missouri. The study’s goal is to evaluate the potential for ...
Breaking Biology Technology:
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health Services ... Management Systems Society (HIMSS) Analytics for achieving Stage ... Model sm . In addition, CHS previously earned ... hospitals using an electronic medical record (EMR). ... high level of EMR usage in an outpatient ...
Breaking Biology News(10 mins):